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Abstract: OBJECTIVE Nosocomial transmission of influenza is a major concern for infection control.
We aimed to dissect transmission dynamics of influenza, including asymptomatic transmission events,
in acute care. DESIGN Prospective surveillance study during 2 influenza seasons. SETTING Tertiary-
care hospital. PARTICIPANTS Volunteer sample of inpatients on medical wards and healthcare workers
(HCWs). METHODS Participants provided daily illness diaries and nasal swabs for influenza A and B
detection and whole-genome sequencing for phylogenetic analyses. Contacts between study participants
were tracked. Secondary influenza attack rates were calculated based on spatial and temporal proximity
and phylogenetic evidence for transmission. RESULTS In total, 152 HCWs and 542 inpatients were
included; 16 HCWs (10.5%) and 19 inpatients (3.5%) tested positive for influenza on 109 study days.
Study participants had symptoms of disease on most of the days they tested positive for influenza (83.1%
and 91.9% for HCWs and inpatients, respectively). Also, 11(15.5%) of 71 influenza-positive swabs among
HCWs and 3 (7.9%) of 38 influenza-positive swabs among inpatients were collected on days without
symptoms; 2 (12.5%) of 16 HCWs and 2 (10.5%) of 19 inpatients remained fully asymptomatic. The
secondary attack rate was low: we recorded 1 transmission event over 159 contact days (0.6%) that
originated from a symptomatic case. No transmission event occurred in 61 monitored days of contacts with
asymptomatic influenza-positive individuals. CONCLUSIONS Influenza in acute care is common, and
individuals regularly shed influenza virus without harboring symptoms. Nevertheless, both symptomatic
and asymptomatic transmission events proved rare. We suggest that healthcare-associated influenza
prevention strategies that are based on preseason vaccination and barrier precautions for symptomatic
individuals seem to be effective.
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Abstract
Objective: Nosocomial transmission of influenza is a major concern for infection control. We aimed to dissect transmission dynamics of
influenza, including asymptomatic transmission events, in acute care.
Design: Prospective surveillance study during 2 influenza seasons.
Setting: Tertiary-care hospital.
Participants: Volunteer sample of inpatients on medical wards and healthcare workers (HCWs).
Methods: Participants provided daily illness diaries and nasal swabs for influenza A and B detection and whole-genome sequencing for phylo-
genetic analyses. Contacts between study participants were tracked. Secondary influenza attack rates were calculated based on spatial and
temporal proximity and phylogenetic evidence for transmission.
Results: In total, 152 HCWs and 542 inpatients were included; 16 HCWs (10.5%) and 19 inpatients (3.5%) tested positive for influenza on 109
study days. Study participants had symptoms of disease onmost of the days they tested positive for influenza (83.1% and 91.9% for HCWs and
inpatients, respectively). Also, 11(15.5%) of 71 influenza-positive swabs among HCWs and 3 (7.9%) of 38 influenza-positive swabs among
inpatients were collected on days without symptoms; 2 (12.5%) of 16 HCWs and 2 (10.5%) of 19 inpatients remained fully asymptomatic. The
secondary attack rate was low: we recorded 1 transmission event over 159 contact days (0.6%) that originated from a symptomatic case. No
transmission event occurred in 61 monitored days of contacts with asymptomatic influenza-positive individuals.
Conclusions: Influenza in acute care is common, and individuals regularly shed influenza virus without harboring symptoms. Nevertheless,
both symptomatic and asymptomatic transmission events proved rare. We suggest that healthcare-associated influenza prevention strategies
that are based on preseason vaccination and barrier precautions for symptomatic individuals seem to be effective.
(Received 2 November 2020; accepted 3 March 2021)
During influenza season, the prevalence of influenza virus in patients
admitted to acute-care hospitals is high.1–5Consequently, nosocomial
transmission and outbreaks of influenza occur in acute care, and
healthcare workers (HCWs) have been involved in transmission
events.6–9 Even vaccinated individuals may be at risk of acquiring
and transmitting the virus, especially because vaccination has been
associated with oligo- or even asymptomatic illness.10,11
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Up to one-third of all study participants with influenza virus
infection do not develop symptoms. In addition, asymptomatic
viral shedding usually precedes clinical illness by 1 day in individ-
uals with symptomatic influenza.12 Although these facts are well
acknowledged, viral shedding and transmission dynamics during
asymptomatic influenza infection remain to be resolved.13–15
A precise understanding of transmission risks associated with
asymptomatic individuals has fundamental implications for influ-
enza prevention strategies in healthcare institutions. Therefore, we
assessed in an acute-care hospital setting whether and to what extent
influenza transmission from asymptomatic individuals occurred.
Materials and methods
Study setting, design, and participants
We conducted a prospective surveillance study at the University
Hospital Zurich, a 900-bed tertiary-care center over 2 consecutive
influenza winter seasons, 2015–16 and 2016–17.
The study methodology has been described in detail else-
where.16 Active surveillance for influenza infection was performed
in all consenting inpatients hospitalized and all consenting HCWs
working on the same wards. The following HCWs were included:
nursing staff, medical staff, corporate hospitality staff with direct
patient contact, and physiotherapists.
We determined the start of the influenza winter season when
the national threshold for an influenza epidemic according to
the Swiss Sentinella Surveillance System was reached.17 The sus-
tained drop of national influenza cases below this threshold for
2 consecutive weeks defined the end of influenza season.
Inpatients were recruited upon admission to the study wards.
From recruitment to discharge from the study ward, a study nurse
collected daily flocked mid-turbinate nasal swabs for influenza
virus detection by polymerase chain reaction (PCR). The nurse also
conducted a short interview using a questionnaire asking for symp-
toms of influenza infection, contact with persons (HCW or visi-
tors) suffering from symptoms of influenza infection, and prior
receipt of influenza vaccine.18 Daily measurements of body tem-
perature were extracted from inpatient electronic medical records
during their hospital stay. Patients were asked to self-collect daily
nasal swabs, questionnaires, and body temperature for 2 more days
after discharge from the study ward.
HCWs were enrolled prior to the influenza season. During the
entire influenza season, HCWs proceeded with daily self-collection
of flocked midturbinate nasal swabs for influenza PCR. They also
completed illness diaries with symptoms of influenza infection, con-
tact with coworkers, inpatients or family member suffering from
symptoms of influenza infection, and study patients cared for.
To avoid bias, the results of the flocked mid-turbinate nasal
swabs from inpatients and HCWswere not made available to study
participants and treating physicians until the end of the study.
Testing for and treatment of influenza infection in inpatients
according to clinical suspicion was the responsibility of the treating
physicians, and infection prevention and control precautions were
guided by the study-independent local infection control team.
Contact tracing
Contacts among HCWs, among inpatients, and between HCWs
and inpatients were tracked through work schedules, bed occupa-
tion plans, and contacts registered in the electronic medical
records, respectively. The contacts in the electronic patient record
system were provided by HCWs on a specific study tab, and routine
electronic activitywas also analyzed.A contactwas defined as eye con-
tact with physical contact (eg, handshake) or a distance between faces
of study participants of<1m if there was no physical contact between
study participants. Once the contacts were traced, the influenza trans-
mission chains were reconstructed.
Laboratory analyses
Influenza detection and whole-genome sequencing. Samples were
analyzed in the accredited diagnostics laboratory of the Institute of
Medical Virology (University of Zurich, Switzerland). Virus transport
medium from flocked midturbinate nasal swab samples was homog-
enized, divided into aliquots, and stored at −20°C until use. Using a
multiplex real-time PCR influenzaA (panA), influenza B (pan B) and
amplification inhibition could be detected and discriminated.
To allow for tracing of transmission chains of influenza virus,
the near full-length genome was amplified directly from the spec-
imens that tested positive for influenza virus RNA, and sequencing
was performed based on next-generation sequencing.19,20
Phylogenetic analyses of transmission events. Likely transmis-
sion events from symptomatic or asymptomatic patients were
identified through epidemiological analyses. Such likely transmis-
sion events were then further corroborated or refuted based on the
phylogenetic analysis (see Supplementary Materials online for
details). Near full-length genome sequences (Supplementary
Table S1 online) were used for characterization of possible trans-
mission events independently. Briefly, study sequences were
pooled with viral sequences from the community. Using BLAST,
the most similar foreign background sequences were identified.21
Subsequently, phylogenetic trees were built using PhyML along-
side 1,000 bootstrap trees.22 Potential transmission clusters were
defined as subtrees with maximum pairwise (GTRþΓ substitution
model-derived) genetic distance below a specified threshold and
with sufficiently high bootstrap support (≥90%). To the best of
our knowledge, there are no consensus thresholds to detect direct
transmission of influenza virus. Based on participants with multi-
ple sequences (Supplementary Table S2 online), we considered a
range of thresholds (Supplementary Fig. S2 online) and deduc-
tively evaluated their plausibility with respect to prevalence of
multiple infections, contact data, and duration of infection and
viral shedding. Thus, we were able to determine reasonable thresh-
olds to be used for the main analysis.
Statistical analysis
In our primary analysis, we described and calculated the secondary
attack rate of asymptomatic or presymptomatic influenza.
Secondary analyses included the secondary attack rates of sympto-
matic influenza infection and the proportions of asymptomatic
and symptomatic participants with influenza among inpatients
and HCWs, risk factors for influenza infection, and the association
of individual influenza symptoms with viral shedding quantified
by cycle threshold (Ct) values from RT-PCR.
Categorical data were tested for differences using the Fisher
exact test, whereas continuous variables were tested using
Wilcoxon rank-sum tests or the Student t test, as appropriate.
Multivariable regression analysis was used to assess indepen-
dent risk factors or predictors for influenza infection and semi-
quantitative influenza shedding, respectively. Clustering was
accounted for, as appropriate, if multiple measurements from
the same individual were included. We considered the following
potential risk factors for influenza infection: participant charac-
teristics, study season (see Supplementary Table S4 online) and
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for analysis of semiquantitative influenza shedding: cough, sore
throat, fever ≥38.0°C, nasal congestion, weakness, headache,
loss of appetite or myalgia. In univariable analyses, variables
with P values < .10 were considered for inclusion in multivari-
able models based on clinical judgment.23
Ethical considerations
The study protocol was approved by the cantonal ethics committee
of the Canton of Zurich (KEK-ZH-Nr.: 2015-0228). Informed
consent of all participants was obtained before enrollment, and
withdrawal from the study was possible at any time.
Results
Recruitment and adherence to the study protocol
In total, 152 HCWs and 542 inpatients from 8 wards in the 2015–
16 and 2016–17 influenza seasons were included, accounting for
40.9% of all eligible healthcare workers and 29.8% of all eligible
inpatients.
Fig. 1. Signs and symptoms of 16
healthcare workers and 19 patients
(panel A) and in relation to days with
positive test results (panel B) diagnosed
with symptomatic or asymptomatic
influenza infection during the 2015–16
and the 2016–17 influenza seasons,
University Hospital Zurich.
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Healthcare worker and inpatient characteristics
Supplementary Table S4 (online) depicts characteristics of study
participants in the 2 influenza seasons. The median duration of
study participation was longer in HCWs in the 2015–16 influenza
season (median, 96 days; range, 71–96) than in the 2016–17 influ-
enza season (median, 66 days; range, 25–67; P < .001) due to a
longer duration of influenza circulation in Switzerland during
the former season.
Influenza cases and symptoms
Overall, 35 participants (5.0%), 16 HCWs (10.5%), and 19 inpa-
tients (3.5%) were diagnosed with influenza, and 31 (88.6%) of
these were infected with influenza A: 13 with influenza A/H1N1
in the 2015–16 season and 1 with influenza A/H1N1 and 17 influ-
enza A/H3N2 in the 2016–17 season. All 4 influenza B cases were
detected in the 2015–16 influenza season. Of 19 influenza infec-
tions in inpatients, 8 (42.1%) were healthcare-associated, and 2
(25.0%) of these 8 were acquired in other institutions. In total,
1,241 swabs were collected in these 35 study participants. Of these,
109 (8.8%) swabs tested positive. The number of positive swabs per
individual ranged from 1 to 13.
The clinical presentation of participants with influenza infec-
tion is depicted in Fig. 1. Moreover, 2 (12.5%) of 16 HCWs and
2 (10.5%) of 19 inpatients remained fully asymptomatic (Fig. 1,
panel A). Receipt of influenza vaccine was not associated with
asymptomatic shedding of influenza virus: 3 (27.3%) of 11 partic-
ipants with asymptomatic shedding and 8 (33.3%) of 24 partici-
pants without asymptomatic shedding had received vaccine
(P= 1.00). Most participants (83.1% of HCWs and 92.1% of inpa-
tients) had signs and symptoms of influenza infection when their
tests were positive, and these were mostly respiratory symptoms
(Fig. 1, panel B). Notably, 11 (15.5%) of 71 influenza-positive
swabs in 8 different HCWs and 3 (7.9%) of 38 influenza-positive
swabs in 3 different inpatients were collected on days without
symptoms.
None of the participant characteristics listed in Supplementary
Table S4 (online) were associated with influenza infection.
Particularly, the risk of influenza infection was not affected by
receipt of vaccine: 24 (4.9%) of 486 unvaccinated participants
and 11 (5.3%) of 208 vaccinated participants were diagnosed with
influenza (P = .85). We detected no independent association
between influenza risk and vaccination status or influenza season.
In multivariable analyses, Ct values were lower in study partic-
ipants shedding influenza A/H1N1with fever (mean Ct value, 29.3;
SD, 0.05) than in those without (mean Ct value, 34.0; SD, 5.7;
P ≤ .001).
Contacts between study participants with influenza,
influenza clusters and transmission events
Overall, we identified 172 contacts between symptomatic and other
study participants and 65 contacts between asymptomatic partic-
ipants with influenza shedding and other study participants
(Table 1). For secondary contacts, at least 1 swab was collected
in the 4 days following the contact for 159 (92.4%) of 172 symp-
tomatic index cases and 61 (93.8%) of 65 asymptomatic index
cases. HCWs reported that they wore masks during work on 18
(81.8%) of 22 days with symptomatic influenza shedding.
Patients with influenza shedding were under droplet precautions
during 1 (33.3%) of 3 contacts when asymptomatic and during
17 (51.5%) of 33 contacts when suffering signs and symptoms
of influenza infection.
Analyses based on spatial and temporal proximity of HCWs
and inpatients revealed 7 clusters of potential influenza transmis-
sion events among HCWs, among inpatients or between HCWs
and inpatients (Fig. 2). All clusters consisted of patients infected
with influenza A. One cluster suggested a possible transmission
from an asymptomatic HCW to an inpatient (Fig. 2, ward B, from
HCWH-IV to patient P4). Another cluster suggested transmission
from a symptomatic patient to an HCW (Fig. 2, ward D, from
patient P15 to HCW H-VI).
Phylogenetic analyses, however, did not support the asympto-
matic transmission event on ward B (Supplementary Fig. S5
online). More precisely, in only 4 (0.4%) of 1,000 bootstrap trees
but not in the most likely phylogenetic tree (Supplementary Fig.
S5 online), the samples of P4 and H- IV formed a monophyletic
group (case 1a in Supplementary Fig. S1 online). In addition,
the minimum genetic distance between their sequences was
0.006329, which was considerably larger than the largest reason-
able upper bound distance (0.0011) of a true transmission cluster
(Supplementary Fig. S2 online and Supplementary Fig. S3 online).
With the genetic distance threshold of 0.00045, 2 of the previously
identified potential transmission pairs could be corroborated from
P15 to H-VI on ward D and between the patients P9 and P10 on
ward C. The phylogenetic evidence was stronger in case of the first
potential transmission pair (P15 toH-VI) because theMRCA clade
of H-VI also contained the sample of P15 (case 2b from
Supplementary Fig. S1 online, occurring in 74.4% of the bootstrap
trees), but this was not the case for the second pair (case 3b from
Supplementary Fig. S1 online, similar in 51.6% of the trees). The
genetic distances and bootstrap support values were similar in both
cases (0.00041 and 99.9%, respectively). These findings were also
consistent with the epidemiological tracing data (Fig. 2). Namely,
while P15 and H-VI had a direct contact, only weak spatial prox-
imity could be detected between P9 and P10 because both patients
were placed in adjacent rooms without direct epidemiologic
contact.
Therefore, based on temporal and spatial proximity and phylo-
genetic analyses and including only secondary contacts with at
Table 1. Contacts of HealthcareWorkers and Inpatients With Influenza Infection
With Other Study Participants During the 2015–16 and the 2016–17 Influenza








No. of days present in hospital
with influenza shedding
30 38
No. of days without symptoms,
n/N (%)
8/30 (26.7) 3/38 (7.9)
No. of susceptible HCWs in contact
with influenza positive index person
152 36
No. of HCWs in contact on days with
asymptomatic shedding, n/N (%)
44/152 (28.9) 3/36 (8.3)
No. of susceptible patients in contact
with influenza positive index person
49 0
No. of patients in contact on days
with asymptomatic shedding, n/N (%)
18/49 (36.7) 0 (0)
Note. HCW, healthcare worker.
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least 1 swab collected in the 4 days following the contact, the sec-
ondary transmission rate was 1 single transmission event in 159
days with contact (0.6%; 95% confidence interval, 0.02%–3.5%)
for infections originating from symptomatic cases and no trans-
mission event in 61 days (0%; 1-sided, 97.5% confidence interval,
0.0%–5.9%) with contact for those originating from asymptomatic
individuals.
Discussion
In a large, prospective surveillance study involving 152 HCWs and
542 hospitalized patients and the collection of >10,500 mid-turbi-
nate nasal swabs and 11,000 illness diaries in the 2015–16 and
2016–17 influenza seasons, we were unable to detect a single case
of asymptomatic transmission of influenza virus that was
Fig. 2. Clusters of influenza cases in healthcare workers and patients according to temporal and spatial proximity, University Hospital Zurich, during the 2015–16 and
2016–17 influenza seasons.
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evident from spatial and temporal proximity and supported by
phylogenetic analysis. Our results indicate that even though
asymptomatic shedding does occur and transmission in the
absence of respiratory symptoms has been hypothesized,12,15,24–27
transmission from asymptomatic shedders in a real-life acute-care
setting seems to be rare if not completely absent. On the other
hand, influenza infections, both symptomatic and asymptomatic,
are a frequent event in the acute-care hospital setting, especially in
HCWs. Thus, several clusters of infection were detected, but only 1
transmission event that was weakly supported by phylogenetic
analyses was identified between a symptomatic inpatient that
transmitted influenza virus to an unvaccinated HCW while not
being under isolation precautions.
We are not aware of any other prospective study that has rig-
orously assessed transmission pathways of influenza infection in
asymptomatic individuals in a real-life acute-care setting.15,27–29
It has been repeatedly claimed that contacts are at risk for influenza
infection when being exposed to someone with asymptomatic viral
shedding. Our results indicates that such risk is probably remote.
Our study was conducted over 2 influenza seasons with 2 different
dominant circulating strains (A/H1N1 in 2015–16, A/H3N2 in
2016–17) in Switzerland, and there was no antigenic mismatch
between circulating strains and vaccine strains in both influenza
seasons, but vaccine effectiveness was nevertheless limited.30,31
Therefore, there is limited risk that strain-specific effects or a mis-
match between influenza vaccine and circulating strains would
play a major role.
Our study has several limitations. It was a prospective, open-
label surveillance study in a single, tertiary-care institution in a
high-income country. Our results may not be generalizable to
other geographic areas or different acute or long-term care insti-
tutions. Nevertheless, the infection control precautions in place
at the study site (ie, hand hygiene policy and self-masking in the
presence of respiratory symptoms) and sick leave during influ-
enza-illness symptoms are comparable to those of other institu-
tions. Sample size issues due to limited participation rates in
both patients and HCWs may have prevented us from detecting
asymptomatic transmission events; the total number of partici-
pants with influenza was low in our study. In 6 HCWs who worked
when being asymptomatic on a day when they tested positive, and
3 additional asymptomatic inpatients, we recorded contacts with
61 other study participants that provided at least 1 swab within
the 4 days following the contact. Even if we assumed that there
was only 1 contact with each other study participant, this would
result in a power of 79% to detect a transmission with a secondary
attack rate of 2.5% and a 96% power to detect a transmission with a
secondary attack rate of 5%. Nevertheless, the total number of
asymptomatic shedding days was low, and we cannot rule out that
individual participant characteristics may have contributed to a
lower attack rate. A major limitation of our study was that we were
unable to track contacts between study participants down to the
resolution of individual face-to-face contacts. However, our esti-
mate of only 1 face-to-face contact on days with asymptomatic
shedding is rather conservative. However, some HCWs may only
have had transient contacts with each other during a single shift.
Apart from asymptomatic transmission events, there was also
no transmission from a symptomatic HCW to an inpatient. As
shown in a previous analysis, a considerable fraction of 67.9% of
all participating HCWs worked with symptoms of influenza infec-
tion on 8.8% of study days,32 but symptomatic HCWs with proven
influenza infection wore masks during work on 18 of 22 days with
symptoms. A Hawthorne effect may have contributed to good
adherence with mask use during these days and may be less pro-
nounced in other individuals. Nevertheless, the study reflects a
real-life situation with gaps in vaccination rates and mask use
among HCWs and delays in the initiation of droplet precautions,
and our findings suggest that these measures are sufficient to pre-
vent transmissions from symptomatic individuals.
In the past, the pathways of spread through individual com-
munities have been revealed through phylogenetic analysis,33
which is capable of disclosing possible transmissions even in the
absence of a documented contact. Only 1 pair of 2 patients without
evident direct contact suggested such an event, indicating that the
number of transmissions through individuals that did not partici-
pate in the study may have been low.
In conclusion, our results indicate that even though asympto-
matic influenza shedding does occur in HCW and inpatients in
acute-care hospitals with multifaceted influenza prevention
polices, transmission events originating from these individuals
seem to be rare if not inexistent.
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